Delivery Order SPE2DB24D2018-SPE2DB25FWVY1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,578.64 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a ciprofloxacin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 10% Suspension in 100ML quantities, with a ceiling value of $2,985.58 and an ultimate completion date of April 22, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,143.32 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cipro 5% Suspension in 100mL quantities, with a ceiling value of $3,020.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,649.57 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Cipro 5% Suspension in 100ml units. This competitive award employs firm fixed-price pricing and carries an ultimate completion date of August 28, 2025, with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $1,875.75 delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML on September 12, 2025, with completion scheduled by September 15, 2025. This firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made competitively without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVY1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December 2026. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order exemplifies the company's role as a prime pharmaceutical supplier under the DLA's comprehensive global pharmaceutical support vehicle, which enables the provision of brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The CIPRO suspension delivery continues AmerisourceBergen's extensive portfolio of antibiotic and pharmaceutical products supporting federal medical supply chain requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/30/25 |